Works matching IS 00070920 AND DT 2005 AND VI 92 AND IP 10

Results: 24

Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cells.
Published in:
British Journal of Cancer, 2005, v. 92, n. 10, p. 1942, doi. 10.1038/sj.bjc.6602546
By:
- Ohyashiki, J. H.;
- Hisatomi, H.;
- Nagao, K.;
- Honda, S.;
- Takaku, T.;
- Zhang, Y.;
- Sashida, G.;
- Ohyashiki, K.
Publication type:
Article
Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.
Published in:
2005
By:
- Máximo, V.;
- Botelho, T.;
- Capela, J.;
- Soares, P.;
- Lima, J.;
- Taveira, A.;
- Amaro, T.;
- Barbosa, A. P.;
- Preto, A.;
- Harach, H. R.;
- Williams, D.;
- Sobrinho-Sim&ampöes, M.;
- Máximo, V;
- Sobrinho-Simões, M
Publication type:
journal article
Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration.
Published in:
British Journal of Cancer, 2005, v. 92, n. 10, p. 1869, doi. 10.1038/sj.bjc.6602551
By:
- Wardley, A.;
- Davidson, N.;
- Barrett-Lee, P.;
- Hong, A.;
- Mansi, J.;
- Dodwell, D.;
- Murphy, R.;
- Mason, T.;
- Cameron, D.
Publication type:
Article
Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas.
Published in:
2005
By:
- Fusco, A.;
- Viglietto, G.;
- Santoro, M.
Publication type:
Editorial
Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors.
Published in:
2005
By:
- Weber, F.;
- Fukino, K.;
- Sawada, T.;
- Williams, N.;
- Sweet, K.;
- Brena, R. M.;
- Plass, C.;
- Caldes, T.;
- Mutter, G. L.;
- Villalona-Calero, M. A.;
- Eng, C.
Publication type:
journal article
Plucked human hair as a tissue in which to assess pharmacodynamic end points during drug development studies.
Published in:
British Journal of Cancer, 2005, v. 92, n. 10, p. 1837, doi. 10.1038/sj.bjc.6602558
By:
- Camidge, D. R.;
- Randall, K. R.;
- Foster, J. R.;
- Sadler, C. J.;
- Wright, J. A.;
- Soames, A. R.;
- Laud, P. J.;
- Smith, P. D.;
- Hughes, A. M.
Publication type:
Article
Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours.
Published in:
British Journal of Cancer, 2005, v. 92, n. 10, p. 1934, doi. 10.1038/sj.bjc.6602560
By:
- Almstrup, K.;
- Hoei-Hansen, C. E.;
- Nielsen, J. E.;
- Wirkner, U.;
- Ansorge, W.;
- Skakkebæk, N. E.;
- Rajpert-De Meyts, E.;
- Leffers, H.
Publication type:
Article
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer.
Published in:
British Journal of Cancer, 2005, v. 92, n. 10, p. 1948, doi. 10.1038/sj.bjc.6602563
By:
- Ballestrero, A.;
- Garuti, A.;
- Bertolotto, M.;
- Rocco, I.;
- Boy, D.;
- Nencioni, A.;
- Ottonello, L.;
- Patrone, F.
Publication type:
Article
Report of a Joint Cancer Research UK/Medical Research Council workshop on cancer cachexia research at the Royal College of Physicians, Tuesday, 2 December 2003.
Published in:
British Journal of Cancer, 2005, v. 92, n. 10, p. 1830, doi. 10.1038/sj.bjc.6602565
By:
- Steer, T. E.
Publication type:
Article
Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas.
Published in:
British Journal of Cancer, 2005, v. 92, n. 10, p. 1927, doi. 10.1038/sj.bjc.6602568
By:
- Gubbay, O.;
- Guo, W.;
- Rae, M. T.;
- Niven, D.;
- Langdon, S. P.;
- Hillier, S. G.
Publication type:
Article
A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer.
Published in:
2005
By:
- Veronese, M. L.;
- Sun, W.;
- Giantonio, B.;
- Berlin, J.;
- Shults, J.;
- Davis, L.;
- Haller, D. G.;
- O'Dwyer, P. J.
Publication type:
journal article
Social and geographic disparities in access to reference care site for patients with colorectal cancer in France.
Published in:
2005
By:
- Dejardin, O.;
- Bouvier, A.-M.;
- Herbert, C.;
- Velten, M.;
- Buemi, A.;
- Delafosse, P.;
- Maarouf, N.;
- Boutreux, S.;
- Launoy, G.
Publication type:
journal article
Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer.
Published in:
2005
By:
- Kim, S. T.;
- Kang, W. K.;
- Kang, J. H.;
- Park, K. W.;
- J. Lee;
- S.-H. Lee;
- Park, J. O.;
- Kim, K.;
- Kim, W. S.;
- Jung, C. W.;
- Park, Y. S.;
- Im, Y. -H.;
- Park, K.;
- Lee, J;
- Lee, S-H
Publication type:
journal article
Intensity-modulated radiation therapy: emerging cancer treatment technology.
Published in:
2005
By:
- Hong, T. S.;
- Ritter, M. A.;
- Tomé, W. A.;
- Harari, P. M.;
- Tomé, W A
Publication type:
journal article
Cancer of the Skin.
Published in:
2005
By:
- Leigh, I. M.
Publication type:
Book Review
The use of radiofrequency in cancer.
Published in:
2005
By:
- Gillams, A. R.
Publication type:
journal article
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours.
Published in:
British Journal of Cancer, 2005, v. 92, n. 10, p. 1855, doi. 10.1038/sj.bjc.6602584
By:
- Awada, A.;
- Hendlisz, A.;
- Gil, T.;
- Bartholomeus, S.;
- Mano, M.;
- de Valeriola, D.;
- Strumberg, D.;
- Brendel, E.;
- Haase, C. G.;
- Schwartz, B.;
- Piccart, M.
Publication type:
Article
Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients.
Published in:
British Journal of Cancer, 2005, v. 92, n. 10, p. 1877, doi. 10.1038/sj.bjc.6602585
By:
- Nishio, M.;
- Ohyanagi, F.;
- Horiike, A.;
- Ishikawa, Y.;
- Satoh, Y.;
- Okumura, S.;
- Nakagawa, K.;
- Nishio, K.;
- Horai, T.
Publication type:
Article
Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients.
Published in:
British Journal of Cancer, 2005, v. 92, n. 10, p. 1862, doi. 10.1038/sj.bjc.6602590
By:
- Greten, T. F.;
- Papendorf, F.;
- Bleck, J. S.;
- Kirchhoff, T.;
- Wohlberedt, T.;
- Kubicka, S.;
- Klempnauer, J.;
- Galanski, M.;
- Manns, M. P.
Publication type:
Article
A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer.
Published in:
British Journal of Cancer, 2005, v. 92, n. 10, p. 1834, doi. 10.1038/sj.bjc.6602591
By:
- Forrest, L. M.;
- McMillan, D. C.;
- McArdle, C. S.;
- Angerson, W. J.;
- Dagg, K.;
- Scott, H. R.
Publication type:
Article
Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines.
Published in:
British Journal of Cancer, 2005, v. 92, n. 10, p. 1881, doi. 10.1038/sj.bjc.6602592
By:
- Uziel, O.;
- Fenig, E.;
- Nordenberg, J.;
- Beery, E.;
- Reshef, H.;
- Sandbank, J.;
- Birenbaum, M.;
- Bakhanashvili, M.;
- Yerushalmi, R.;
- Luria, D.;
- Lahav, M.
Publication type:
Article
Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder.
Published in:
British Journal of Cancer, 2005, v. 92, n. 10, p. 1906, doi. 10.1038/sj.bjc.6602593
By:
- H. -L. Cheng;
- H.-S. Liu;
- Y.-J. Lin;
- H. H. -W Chen;
- P. -Y. Hsu;
- T. -Y. Chang;
- C. -L. Ho;
- T. -S. Tzai;
- N. -H. Chow
Publication type:
Article
Aberrant expression of RAB1A in human tongue cancer.
Published in:
British Journal of Cancer, 2005, v. 92, n. 10, p. 1915, doi. 10.1038/sj.bjc.6602594
By:
- Shimada, K.;
- Uzawa, K.;
- Kato, M.;
- Endo, Y.;
- Shiiba, M.;
- Bukawa, H.;
- Yokoe, H.;
- Seki, N.;
- Tanzawa, H.
Publication type:
Article
The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells.
Published in:
2005
By:
- Mandal, M.;
- Kim, S.;
- Younes, M. N.;
- Jasser, S. A.;
- El-Naggar, A. K.;
- Mills, G. B.;
- Myers, J. N.
Publication type:
journal article